This year, so far, dividend investors are dealing with underperformance as the market has shifted from value to growth stocks. This is amplified by economic growth fears. While underperformance isn't
The economic data is getting worse at an accelerating rate. It now appears a 1.7% GDP recession lasting nine months could start in 5 weeks. The eerie calm of the market is 100% driven by an AI bubble
CSL is an underappreciated dividend growth stock with a strong business model and a track record of outperforming the market. CSL operates in the industrial sector, focusing on building products throu
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.
This article is part of our monthly series where we highlight five companies that are large-cap, relatively safe, dividend-paying and are offering large discounts to their historical norms. We go over
Carlisle's (CSL) first-quarter 2023 earnings decline 39.7% on a year-over-year basis due to lower sales.
Let's face reality – the concept of infrastructure stocks to buy, no matter how well it's dressed up is terribly boring. I get it. At the same time, these enterprises quite literally undergird the m

Earn Double-Digit Income With Options (May 2023)

09:00am, Saturday, 29'th Apr 2023
We explain why selling cash-covered puts and covered calls are relatively safe choices for earning a high income. We will discuss how to formulate an options income strategy that's sustainable and rep
Carlisle (CSL) came out with quarterly earnings of $2.57 per share, missing the Zacks Consensus Estimate of $2.62 per share. This compares to earnings of $4.26 per share a year ago.
Get Ready To Back Up The Truck On 10 Coiled-Spring Dividend Aristocrats.
12 Dividend Aristocrats That Should Leave You Swimming In Cash.
Carlisle (CSL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 Stocks You Can Keep Forever

10:15am, Sunday, 16'th Apr 2023
AbbVie is expected to recover within two years from Humira's patent cliff. Parker-Hannifin is benefiting from increased aerospace spending.
Carlisle (CSL) experiences raw material cost inflation, coupled with supply-chain woes. Unfavorable foreign-currency movements are added concerns.
The cost of building materials increased by 25% between 2021 and 2022. Many businesses in this industry have profited from higher prices to boost their top and bottom lines, but their long-term viabil
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE